Other top stories

The Advantages of Long-Acting Injectables in Early-Phase Schizophrenia

May 8, 2023

Smiley Emojis Sometimes Mask Sad Feelings, Study Finds

May 8, 2023

The Weekly Mind Reader: Ghrelin, Anxiety, and Disordered Eating

May 5, 2023

Experimental Alzheimer's Drug Donanemab Shows Promise in Slowing Cognitive Decline

May 4, 2023

A Reason for Hope in Rett Syndrome: New Medications, Novel Gene Therapies

May 3, 2023

Slow-Release UZEDY Gains FDA Approval, Reduces Schizophrenia Relapse by 80%

May 2, 2023